IN THE NEWS
May 21, 2018:
Avenue Therapeutics Announces Positive Topline Phase 3 Data for Intravenous Tramadol in the Management of Postoperative Pain
May 15, 2018:
Fortress Biotech Appoints Michael G. King, Jr. as Entrepreneur in Residence
May 14, 2018:
Mustang Bio Reports First Quarter 2018 Financial Results
May 10, 2018:
Fortress Biotech Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
Checkpoint Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
May 3, 2018:
Avenue Therapeutics Reports First Quarter 2018 Financial Results and Recent Corporate Highlights
QUICK LINKS
PIPELINE
